News: Molecular Biosciences

The discovery could also lend itself to the development of future antibacterial therapies.

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

An innovative imaging technique enabled dramatically higher resolution structures than previous efforts.

The professor of molecular biosciences at The University of Texas at Austin was one of 16 new fellows named.

A new antibody design blocks cytomegalovirus from hiding from the immune system and could lead to safer, more effective treatments for vulnerable patients.

Tu-Quyen Dao, a senior biochemistry student, is studying how AI can be applied to improve healthcare.

The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.

Advanced biotechnology repurposes two bacterial immune systems to correct large stretches of DNA.

Could AI be the key to curing cancer? Meet the leader of a new research team putting that question to the test.

The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.